Clinical Trial Update: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial of mycophenolate mofetil in progressive idiopathic membranous nephropathy has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy
• Membranous Nephropathy

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Glomerulonephritis, Membranous | Phase 3 | Status: COMPLETED | Results posted: 2025-08-27